Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients

Fig. 3

Adipogenic differentiation of IPFaMSCs and HCaMSCs. A. Representative images of undifferentiated and adipogenic differentiated (a) HCaMSC and (b) IPFaMSC. Scale bar = 200 μm. B. Unpaired Student's t test was used for analyzing the statistical differences of adipogenesis in undifferentiated HCaMSC and IPFaMSC. No significant difference in growth rate in nonadipogenic media between these two groups was found, with median values of 588 (GCU x mm2/well)/cell and 353 (GCU x mm2/well)/cell, respectively. No significant difference was found between adipogenic capacity of HCaMSC and IPFaMSC with median values of 1768 (GCU x mm2/well)/cell and 1408 (GCU x mm2/well)/cell, respectively. Significant difference was found between undifferentiated and adipogenic differentiated HCaMSC as well as between undifferentiated and adipogenic differentiated IPFaMSC. Dots represent individual cell lines values. **p < 0.01, compared with control cell lines

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512